Robotic Radiotherapy Market Size & Outlook, 2026-2034

Robotic Radiotherapy Market Overview

The global robotic radiotherapy market size is valued at USD 1.52 billion in 2025 and is estimated to reach USD 3.66 billion by 2034, growing at a CAGR of 10.26% during the forecast period. The consistent market growth is fuelled by the rising adoption of tumor tracking systems, which allow motion-adaptive radiotherapy.

Key Market Trends & Insights

• North America held a dominant revenue share of the global market, accounting for 37.49% in 2025.
• The Asia Pacific region is growing at the fastest pace, with a CAGR of 11.88% during 2026-2034.
• By product, the radiotherapy system segment dominated the market, accounting for 36.02% revenue share in 2025.
• Based on technology, the LINAC segment held the highest market share of 45.16% in 2025.
• By application, the colorectal cancer segment is expected to register the fastest CAGR growth of 11.42%
• Based on end user, the hospitals segment dominated the market in 2025.
• The U.S. dominates the market, valued at USD 469.73 million in 2024 and reaching USD 515.90 million in 2025.

Table: U.S. Robotic Radiotherapy Market Size (USD Million)

Source: Straits Research

Market Size & Forecast

• 2025 Market Size: USD 1.52 billion
• 2034 Projected Market Size: USD 3.66 billion
• CAGR (2026-2034): 10.26%
• Dominating Region: North America
• Fastest-Growing Region: Asia Pacific

The robotic radiotherapy market encompasses advanced radiation treatment systems, software platforms, 3D imaging technologies, and others. Leveraging technologies such as LINAC, stereotactic systems, particle therapy, and proton beam therapy, these platforms support applications across major cancer types, including lung, breast, colorectal malignancies, and others. Hospitals and specialized radiotherapy centers utilize robotic radiotherapy to enhance patient outcomes in oncology care.

Latest Market Trends

Growing Adoption of Adaptive Radiotherapy Platforms

A key trend in the robotic radiotherapy market is the rising adoption of adaptive radiotherapy systems that modify treatment plans in real time based on daily anatomical changes. These platforms integrate advanced imaging, automation, and AI-driven analytics to enhance tumor targeting accuracy while minimizing exposure to healthy tissues. Their ability to personalize radiation delivery for each session is driving wider clinical adoption and improving outcomes in complex cancer treatments.

Integration of Cloud-based AI Planning Systems

The growing integration of cloud-based AI platforms to enhancing treatment planning precision and workflow efficiency. Vendors are increasingly leveraging scalable cloud infrastructures to support automated contouring, real-time data analysis, and adaptive plan optimization. For example, Varian expanded its collaboration with Google Cloud to strengthen AI-driven radiotherapy planning capabilities, enabling faster computation and improved decision support. This shift reflects the industry’s movement toward intelligent, connected, and data-optimized oncology ecosystems.

To get more insights about this report Download Free Sample Report

Market Driver

Rising Demand For Precision Oncology Boosts Adoption of Robotic Radiotherapy

A key driver in the robotic radiotherapy market is the increasing clinical demand for high-precision radiation treatment to manage complex tumors. Robotic systems equipped with real-time tumor tracking and adaptive motion management enable clinicians to deliver targeted therapy with minimal damage to surrounding tissues. Recently, Accuray introduced enhancements to its CyberKnife platform to improve sub-millimeter accuracy for lung and prostate cancer treatment. This growing emphasis on precision-driven oncology is accelerating global adoption of robotic radiotherapy solutions.

Market Restraint

Limited Availability of Skilled Radiotherapy Professionals

The shortage of trained radiation oncologists, medical physicists, and technologists capable of operating advanced robotic treatment systems. These platforms require expertise in imaging, adaptive planning, and precision dose delivery, creating operational challenges in regions with limited specialized workforce capacity. According to the International Atomic Energy Agency, over 40% of low-income countries face critical radiotherapy staffing shortages, slowing the adoption of robotic systems and limiting treatment accessibility across emerging markets.

Market Opportunity

Growing Penetration of AI-enabled Adaptive Therapy in Emerging Markets

A key opportunity in the Robotic Radiotherapy Market lies in the rapid expansion of AI-enabled adaptive therapy solutions across emerging economies. As cancer incidence rises, countries such as India, Brazil, and South Africa are increasingly investing in next-generation radiotherapy to enhance treatment accuracy. According to the WHO, nearly 70% of global cancer deaths occur in low- and middle-income countries, creating strong demand for affordable, precision-focused robotic systems. This rising clinical demand presents substantial growth potential for manufacturers offering cost-efficient, AI-driven robotic radiotherapy platforms.

Regional Analysis

North America dominated the market in 2025, accounting for 37.49% market share. Growth in the region is supported by the rapid integration of radiomics-driven treatment planning in robotic radiotherapy centers. Leading institutions increasingly use quantitative imaging biomarkers to personalize dose strategies, improving outcomes and accelerating the adoption of advanced robotic platforms across research-oriented oncology networks in the region.

The U.S. robotic radiotherapy market is experiencing unique growth driven by the expansion of precision-focused clinical trial networks incorporating robotic radiotherapy as a core modality. Major cancer institutes are integrating robotic platforms into federally supported research programs, enabling rapid validation of novel treatment protocols and accelerating nationwide adoption through evidence-backed clinical outcomes and standardized best-practice models.

Asia Pacific Market Insights

Asia Pacific is emerging as the fastest-growing region with a CAGR of 11.88% from 2026-2034. The growth is attributed to the rising deployment of cost-efficient, compact robotic radiotherapy systems in tier-2 and tier-3 cities. These smaller footprint installations enable regional cancer centers to offer high-precision treatments, expanding accessibility beyond metropolitan areas and addressing the growing oncology burden across emerging markets.

Australia's robotic radiotherapy market is growing due to the integration of remote monitoring and tele-radiotherapy capabilities in robotic systems. This allows clinicians to supervise and adjust treatments across geographically dispersed cancer centers, improving access, workflow efficiency, and adoption of advanced radiotherapy in remote and regional areas.

Regional Market share (%) in 2025

Source: Straits Research

Europe Market Insights

Europe is witnessing strong growth in the robotic radiotherapy market, driven by the implementation of government-funded precision oncology initiatives that prioritize robotic radiotherapy adoption. Countries like Germany and France are investing in advanced treatment infrastructure, enabling widespread deployment of robotic systems in public hospitals and specialized cancer centers.

Germany's robotic radiotherapy market is stimulated by the government-backed incentives for upgrading existing radiotherapy centers with particle therapy-capable robotic systems. These subsidies and funding programs encourage hospitals to adopt high-precision proton and carbon ion therapy, expanding advanced treatment options and strengthening the country’s leadership in oncology care.

Latin America Market Insights

The Latin American market is benefiting from the emergence of public-private partnerships to establish regional robotic radiotherapy hubs. These collaborations enable smaller countries to access advanced treatment technologies, improve oncology infrastructure, and expand high-precision cancer care to underserved populations across the region.

The Brazilian market is propelled by the rapid adoption of mobile robotic radiotherapy units for remote and underserved regions. These transportable systems allow hospitals to provide high-precision cancer treatment in areas with limited infrastructure, expanding patient access and regional oncology care coverage.

Middle East and Africa Market Insights

The Middle East and Africa market is being driven by the rapid adoption of robotic stereotactic body radiotherapy for prostate and liver cancers in high-income Gulf countries. Investments in state-of-the-art cancer centers in the UAE and Saudi Arabia are accelerating the deployment of these precision robotic systems, catering to a growing demand for minimally invasive, high-dose radiotherapy treatments in the region.

The UAE market is benefiting from the implementation of fully networked, cloud-based robotic radiotherapy systems across multiple hospital chains, allowing centralized treatment planning, remote QA, and inter-hospital collaboration, which improves workflow efficiency and expands access to advanced oncology treatments nationwide.

Product Insights

The radiotherapy system dominated the market, accounting for 36.02% revenue share in 2025. This growth is attributed to the increasing adoption of motion synchronization radiotherapy systems for treating highly mobile tumors. These platforms dynamically adjust radiation delivery based on real-time respiratory and organ motion, enabling superior accuracy in complex thoracic and abdominal cancer treatments.

The software segment is projected to grow at a CAGR of 10.85% during the forecast period, due to the rising integration of automated contouring software powered by adaptive machine-learning models. These tools reduce manual planning time, enhance consistency in tumor and organ delineation, and streamline radiotherapy workflows, accelerating clinical adoption.

By Product Market Share (%), 2025

Source: Straits Research

Technology Insights

The LINAC segment dominated the market with a revenue share of 45.16% in 2025. This dominance is attributed to the expanded use of flattening-filter-free (FFF) beam technology. This capability enables dose rate treatments, notably reducing session times while maintaining precision, making LINAC systems the preferred choice for high-throughput cancer centers.

The proton beam therapy segment is projected to grow at a CAGR of 10.91% during 2026-2034, owing to increasing adoption of single-room proton therapy systems. These smaller footprint units reduce installation and facility costs, allowing more regional cancer centers to offer proton therapy and widening access to precision-focused radiation treatments.

Application Insights

The lung cancer segment dominated the market with a revenue share of 41.63% in 2025. This dominance is augmented by the growing use of radiotherapy systems optimized for treating ultra-central lung tumors, where proximity to critical structures demands sub-millimeter precision. Advanced robotic platforms tailored for these high-risk cases are increasingly preferred, reinforcing strong adoption in lung cancer care.

The colorectal cancer segment is anticipated to register the fastest CAGR of 11.42% during 2026-2034. This strong growth is driven by the growing adoption of image-guided radiotherapy tailored for pelvic organ motion management. Advanced robotic systems that track and adjust for bowel and rectal movement during treatment improve targeting accuracy, making them highly effective for complex colorectal cancer cases.

End User Insights

The hospitals segment dominated the market in 2025, due to hospitals’ expanded deployment of hybrid treatment suites integrating robotic radiotherapy with on-site diagnostic MRI or PET imaging. This real-time imaging capability enables immediate treatment adaptation, enhancing precision and attracting complex oncology cases predominantly to hospital-based facilities.

Competitive Landscape

The global robotic radiotherapy market is moderately consolidated, dominated by key players such as Siemens Healthineers, Elekta, Accuray, ViewRay, and Brainlab. These companies focus on strategic initiatives, including product innovation, AI integration, and expansion into emerging markets. Continuous R&D, partnerships, and acquisitions are enhancing their technological capabilities and market reach. Such competitive strategies drive market growth while reinforcing their leadership positions in precision oncology and robotic radiotherapy solutions worldwide.

RefleXion Medical: An Emerging Market Player

RefleXion Medical is an emerging innovator in the global market, specializing in biology-guided radiotherapy systems that combine PET imaging with precision radiation delivery. In 2025, the company expanded its clinical installations across leading U.S. cancer centers, enabling highly targeted treatment for complex tumors. RefleXion’s focus on integrating AI-driven imaging with adaptive therapy positions it as a key growth player in robotic radiotherapy solutions.

List of key players in Robotic Radiotherapy Market

1. Accuray Incorporated
2. Bionix Radiation Therapy
3. CIVCO Radiotherapy
4. Elekta
5. GE Healthcare
6. Hitachi, Ltd.
7. Koninklijke Philips N.V.
8. KUKA AG
9. Mevion Medical Systems
10. MIM Software Inc.
11. Mitsubishi Electric Corporation
12. Panacea Medical Technologies Pvt. Ltd.
13. P-Cure
14. ProNova Solutions, LLC
15. RaySearch Laboratories
16. RefleXion Medical
17. Shinva Medical Instrument Co., Ltd.
18. Sumitomo Heavy Industries Ltd.
19. United Imaging Healthcare
20. Others

To get more findings about this report Download Market Share

Strategic Initiatives

• September 2025: Accuray Incorporated launched the Accuray Stellar Solution, designed to empower clinical teams to address the evolving treatment for patients undergoing radiotherapy.
• January 2025: Accuray Incorporated received approval for the Radixact SynC System and CyberKnife S7 System from the Chinese National Medical Products Administration (NMPA).